Acadia Pharmaceuticals Inc. Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$23.89$24.92
1.28%
Downside
2.98%
Upside
52 Week's Low
52 Week's High
$13.4$26.6544.63%
Downside
10.12%
Upside
Acadia Pharmaceuticals Inc. share price movements today
- Previous Close
- $23.96
- Open
- $24.09
- Volume
- 1.1M
- Day's Low - High
- $23.89 - $24.92
- 52 Week Low - High
- $13.4 - $26.65
Acadia Pharmaceuticals Inc. Historical Returns
- 1 Month Return
- -5.41 %
- 3 Month Return
- + 5.09 %
- 1 Year Return
- + 47.36 %
- 3 Year Return
- + 32.96 %
- 5 Year Return
- -41.22 %
Acadia Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Check Acadia Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.2B
EPS (TTM)
0.5409
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.21%
PE Ratio (TTM)
18.57
Industry PE ratio
10.127857142857144
P/B Ratio
18.5736
PEG Ratio
-0.42
EBITDA
104.0M
Revenue (TTM)
1.0B
Profit Margin
21.80%
Return On Equity TTM
33.18%
Acadia Pharmaceuticals Inc. Stock Valuation
Track how Acadia Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Acadia Pharmaceuticals Inc. in the last 5 years
Lowest (11.87x)
December 31, 2024
Industry (10.13x)
September 17, 2025
Today (18.57x)
September 17, 2025
Highest (89.66x)
June 30, 2024
Today’s Price to Earnings Ratio: 18.57x
Acadia Pharmaceuticals Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Acadia Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.2B | -41.22% | 18.57 | 21.80% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Acadia Pharmaceuticals Inc. Stock including INR - Dollar returns
The Acadia Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acadia Pharmaceuticals Inc. investment value today
Current value as on today
₹1,53,430
Returns
₹53,430
(+53.43%)
Returns from Acadia Pharmaceuticals Inc. Stock
₹48,831 (+48.83%)
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Acadia Pharmaceuticals Inc. Stock
Based on 26 analysts
73.08%
Buy
23.08%
Hold
3.85%
Sell
Based on 26 analysts, 73.08% of analysts recommend a 'BUY' rating for Acadia Pharmaceuticals Inc.. Average target price of $30.32
Acadia Pharmaceuticals Inc. Share Price Target
Get share price movements and forecasts by analysts on Acadia Pharmaceuticals Inc..
What analysts predicted
20.18%UPSIDE
Target Price
$30.32
Current Price
$24.2
Analyzed by
26 Analysts
Target
$30.32
Acadia Pharmaceuticals Inc. target price $30.32, a slight upside of 20.18% compared to current price of $24.2. According to 26 analysts rating.
Acadia Pharmaceuticals Inc. Stock's Interest Amongst Investors
Search interest for Acadia Pharmaceuticals Inc. Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Acadia Pharmaceuticals Inc. Quarterly Profit & Loss
All numbers in Millions USD
Acadia Pharmaceuticals Inc. Annual Profit & Loss
All numbers in Millions USD
Acadia Pharmaceuticals Inc. Quarterly Cash Flow
All numbers in Millions USD
Acadia Pharmaceuticals Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Acadia Pharmaceuticals Inc.
Insights on Acadia Pharmaceuticals Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 244.31M → 264.56M (in $), with an average increase of 7.7% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 18.98M → 26.66M (in $), with an average increase of 28.8% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 83.5%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 20.7%
NEGATIVE IMPACTPrice Dip
In the last 1 month, ACAD stock has moved down by -5.4%
About Acadia Pharmaceuticals Inc.
| Organisation | Acadia Pharmaceuticals Inc. |
| Headquarters | 12830 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Ms. Catherine E. Owen Adams |
| E-voting on shares | Click here to vote |
Key Management of Acadia Pharmaceuticals Inc.
Name | Title |
|---|---|
Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary |
Dr. Elizabeth H. Z. Thompson Ph.D. | Executive VP and Head of Research & Development |
Mr. Scott Cenci | Senior VP, Chief Information & Data Officer |
Mr. James K. Kihara | Senior Vice President of Finance |
Ms. Allyson McMillan Youngblood | Senior Vice President of Rare Disease Franchise |
Ms. Catherine E. Owen Adams | CEO & Director |
Mr. Mark C. Schneyer | Executive VP & CFO |
Mr. Rob Ackles | Senior VP & Chief People Officer |
Mr. Stephen R. Davis J.D. | Consultant |
Mr. Thomas Andrew Garner | Executive VP & Chief Commercial Officer |
FAQs
What is Acadia Pharmaceuticals Inc. share price today?
Acadia Pharmaceuticals Inc. share price today is $24.2 as on at the close of the market. Acadia Pharmaceuticals Inc. share today touched a day high of $24.92 and a low of $23.89.
What is the 52 week high and 52 week low for Acadia Pharmaceuticals Inc. share?
Acadia Pharmaceuticals Inc. share touched a 52 week high of $26.65 on and a 52 week low of $13.4 on . Acadia Pharmaceuticals Inc. stock price today i.e. is closed at $24.2,which is 9.19% down from its 52 week high and 80.60% up from its 52 week low.
What is Acadia Pharmaceuticals Inc.'s market capitalisation today?
Acadia Pharmaceuticals Inc. market capitalisation is $0.00T as on .
How to invest in Acadia Pharmaceuticals Inc. Stock (ACAD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Acadia Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acadia Pharmaceuticals Inc. Shares that will get you 0.0620 shares as per Acadia Pharmaceuticals Inc. share price of $24.2 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Acadia Pharmaceuticals Inc. Stock (ACAD) from India?
Indian investors can start investing in Acadia Pharmaceuticals Inc. (ACAD) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Acadia Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Acadia Pharmaceuticals Inc. share’s latest price of $24.2 as on September 18, 2025 at 1:29 am IST, you will get 0.4132 shares of Acadia Pharmaceuticals Inc.. Learn more about
fractional shares .
What are the returns that Acadia Pharmaceuticals Inc. has given to Indian investors in the last 5 years?
Acadia Pharmaceuticals Inc. stock has given -41.22% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?